These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19. Assessment of the tumor-associated trypsin inhibitor (TATI) marker in patients with carcinoma of the uterine body 17 years after treatment. Kozakiewicz B; Chadzyńska M; Dmoch-Gajzlerska E Eur J Gynaecol Oncol; 2014; 35(1):39-43. PubMed ID: 24654459 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Lukkonen A; Lintula S; von Boguslawski K; Carpén O; Ljungberg B; Landberg G; Stenman UH Int J Cancer; 1999 Nov; 83(4):486-90. PubMed ID: 10508484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]